Piperazine-2,6-dione, 95.0%, 1g

Ethyl 2-{7-hydroxy-1H,2H,3H,4H-cyclopenta[b]indol-3-yl}acetate, 97%, 100mg

Methyl 2-amino-4-bromo-3,6-difluorobenzoate, 500mg

N-Methylnicotinamide>98.0%(GC)(T)10g

Ethyl 1H-pyrrolo[2,3-b]pyridine-4-carboxylate, 97%, 5g

2-Butanol, min 98.5%, pour synthèse, 1L, conditionnement verre

8-(4-Chlorophenyl)-1,4-dioxaspiro[4.5]decane, 95+%, 250mg

Methyl 2-chloro-5-methoxybenzoate, 95.0%, 10g

(S)-(-)-1-Methyl-2-(1-piperidinomethyl)pyrrolidine>97.0%(GC)(T)5g

Methyl 4-amino-2-methylbenzoate, 97.0%, 25g

(+)-Limonene>99.0%(GC)25mL

p-Tolyl disulfide, 98.0%, 500g

Fmoc-D-Asp(OtBu)-OH, 98%, 25g